Company Filing History:
2 out of 1,645 
1 out of 3,539 
1 out of 376 
Years Active: 2013-2019
Title: Kent Lai: Innovator in Galactokinase Inhibitors
Introduction
Kent Lai is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of biochemistry, particularly in the development of galactokinase inhibitors. With a total of 3 patents to his name, his work focuses on innovative solutions for treating and preventing diseases associated with galactokinase.
Latest Patents
Kent Lai's latest patents include groundbreaking research on galactokinase inhibitors for the treatment and prevention of associated diseases and disorders. These patents disclose inhibitors of human galactokinase that are useful in treating or preventing galactokinase-mediated diseases, such as galactosemia. The patents also describe a composition comprising a pharmaceutically acceptable carrier and at least one inhibitor of the invention, along with methods for treating or preventing such diseases in mammals.
Career Highlights
Throughout his career, Kent Lai has worked with esteemed organizations such as the University of Utah Research Foundation and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Kent has collaborated with notable colleagues, including Manshu Tang and Matthew Brian Boxer. These partnerships have further enriched his research and innovation in the field.
Conclusion
Kent Lai is a distinguished inventor whose work on galactokinase inhibitors has the potential to make a significant impact on the treatment of related diseases. His contributions to biochemistry and collaboration with leading institutions highlight his commitment to advancing medical science.